Oranda Therapeutics
About Oranda Therapeutics
Oranda Therapeutics specializes in the acquisition and commercialization of late-stage rare disease therapies, focusing on enhancing patient access to essential medicines in Europe. The company addresses the significant gap in available treatments for life-threatening and chronically debilitating conditions by leveraging its expertise in market access and product licensing.
```xml <problem> Many patients in Europe with rare, life-threatening, or chronically debilitating diseases lack access to essential medicines due to challenges in commercializing and distributing these therapies. BioPharma SMEs often face difficulties in navigating the complexities of European market access, hindering the availability of innovative treatments for those who need them most. </problem> <solution> Oranda Therapeutics specializes in acquiring and commercializing late-stage rare disease therapies, focusing on improving patient access to these medicines across Europe. The company partners with BioPharma SMEs to bring innovative medicines to patients with unmet medical needs. By leveraging expertise in market access, pricing, reimbursement, and product licensing, Oranda Therapeutics aims to bridge the gap between pharmaceutical innovation and patient availability, ensuring that essential treatments reach those who can benefit from them. </solution> <features> - Expertise in European market access for rare disease therapies - Focus on commercializing late-stage products to expedite patient access - Strategic partnerships with BioPharma SMEs to expand product portfolios - Specialization in pricing and reimbursement strategies across diverse European markets - Streamlined distribution channels to ensure efficient delivery of medicines </features> <target_audience> The primary target audience includes BioPharma SMEs with innovative rare disease therapies seeking to commercialize their products in the European market, as well as European patients with rare, life-threatening, or chronically debilitating conditions who lack access to essential medicines. </target_audience> ```
What does Oranda Therapeutics do?
Oranda Therapeutics specializes in the acquisition and commercialization of late-stage rare disease therapies, focusing on enhancing patient access to essential medicines in Europe. The company addresses the significant gap in available treatments for life-threatening and chronically debilitating conditions by leveraging its expertise in market access and product licensing.
Where is Oranda Therapeutics located?
Oranda Therapeutics is based in United Kingdom.
When was Oranda Therapeutics founded?
Oranda Therapeutics was founded in 2023.
How much funding has Oranda Therapeutics raised?
Oranda Therapeutics has raised 37890000.
- Location
- United Kingdom
- Founded
- 2023
- Funding
- 37890000 0